Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Royal Free Hospital NHS Foundation Trust | OTHER |
Not provided
Not provided
Not provided
The goal of this observational study is to determine if a COPD exacerbation can be detected early in its onset. The main questions it aims to answer are:
Participants will be asked to place a device, DistaSense, on top of their mattress and then sleep as normal. In addition, they will be asked to complete a daily CAT.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| COPD patients | Group will consist of individuals who have been diagnosed with COPD, living in their home and not recently discharged from the hospital for an exacerbation. | ||
| Discharged COPD patients | Group will consist of individuals who have been diagnosed with COPD, living in their home, and are being discharged from the hospital for an exacerbation. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Track the adherence of DistaSense | To evaluate the adherence of patients using DistaSense, a non-contact vital sign monitor that measures heart rate and respiration rate, we will be tracking the patient dropout rate over the course of the 12 month study period. | 12 months |
| Understand the patient acceptance of DistaSense | To evaluate the patient acceptance of using DistaSense, a non-contact vital sign monitor that measures heart rate and respiration rate, we will be requesting patients complete a Technology Assessment Model Fast Form (TAM-FF) every 3 months during the 12 month trial period. | 12 months |
| Ability to detect COPD exacerbations | To evaluate the ability of a non-contact remote monitoring techniques to detect exacerbations of COPD. | 3 - 12 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death affecting an estimated 238 million worldwide. It is a heterogeneous disease which is characterized by air flow obstruction and decline in lung function with symptoms of shortness of breathing, sputum, and cough.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Eric Howie | Contact | 4084213151 | ehowie@distasense.com | |
| Peter Rule | Contact | 6502795261 | prule@distasense.com |
| Name | Affiliation | Role |
|---|---|---|
| John Hurst | University College, London | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Royal Free Hospital | Recruiting | London | United Kingdom |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided